drugset
drugset / Trial / NCT01817023

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

NCT01817023 ↗

Phase 3 Unknown 590 enrolled Chinese Academy of Medical Sciences
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to verify that simultaneous integrated boost IMRT (SIB-IMRT) alone is non-inferior to SIB-IMRT combined with concurrent chemotherapy for low-risk locally advanced nasopharyngeal carcinoma.

Timeline

Start
2013-04
Primary completion
2019-07-30
Completion
2021-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified 100 mg/m2 —

Indications

nasopharyngeal carcinoma